ESMO 2012 Press Releases

Date Title Topic
01 Oct 2012 ESMO 2012 Press Release : New findings on optimal duration of trastuzumab therapy for women with HER2-positive early breast cancer Breast cancer
20 Sep 2012 ESMO 2012 Press Release: Cancer in the Movies Translational research
30 Sep 2012 ESMO 2012 Press Release: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer Lung and other thoracic tumours
28 Sep 2012 ESMO 2012 Press Release: Will bureaucracy stifle the development of new cancer treatments? Bioethics, legal and economic issues
28 Sep 2012 ESMO 2012 Press Release: The true costs of cancer in Europe revealed Bioethics, legal and economic issues
30 Sep 2012 ESMO 2012 Press Release: Are too few women being offered breast-conserving treatment? Breast cancer
29 Sep 2012 ESMO 2012 Press Release: Many cancer patients unaware of the personalised medicine revolution in oncology, survey shows Personalised medicine
01 Oct 2012 ESMO 2012 Press release: Phase III data in treatment of renal cell carcinoma reported Gastrointestinal cancers - Anticancer agents & Biologic therapy
01 Oct 2012 ESMO 2012 Press release: First large scale trial of whole-genome cancer testing for clinical decision-making reported Breast cancer
24 Sep 2012 ESMO 2012 Press Release: Urgent need for integrated oncology and palliative care Palliative and supportive care
29 Sep 2012 ESMO 2012 Press Release: Phase III MISSION trial Lung and other thoracic tumours
01 Oct 2012 ESMO 2012 Press Release: Should aspirin be used to prevent cancer? Gastrointestinal cancers
30 Sep 2012 ESMO 2012 Press Release: New weapons in the fight against cancer Basic science
01 Oct 2012 ESMO 2012 Press Release: Studies show advances in gastrointestinal cancer treatments Gastrointestinal cancers
02 Oct 2012 ESMO 2012 Press Release: Equal access to cancer care is a medical and ethical imperative Bioethics, legal and economic issues